|
|
||||||||
Address correspondence to Kazimierz S. Kasprzak, Ph.D., Laboratory of Comparative Carcinogenesis, Bldg. 538, Room 205E, National Cancer Institute at Frederick, Frederick, MD 21702, USA; tel 301 846 5738; fax 301 846 5946; e-mail kasprkaz{at}mail.ncifcrf.gov.
Nickel(II), capable of transforming cells and causing tumors in humans and animals, has been previously shown by us to mediate hydrolytic truncation of histone H2As C-terminal tail by 8 amino acids in both cell-free and cell culture systems. Since H2As C-tail is involved in maintaining chromatin structure, such truncation might alter this structure and affect gene expression. To test the latter possibility, we transfected cultured T-REx 293 human embryonic kidney cells with plasmids expressing either wild type (wt) or truncated (q) histone H2A proteins, which were either untagged or N-terminally tagged with fluorescent proteins. Each histone variant was found to be incorporated into chromatin at 24 and 48 hr post-transfection. Cells transfected with the untagged plasmids were tested for gene expression by microarray and real-time PCR. Evaluation of the results for over 21,000 genes using the multidimensional scaling and hierarchical clustering methods revealed significant differences in expression of numerous genes between the q-H2A and wt-H2A transfectants. Many of the differentially expressed genes, including BAZ2A, CLDN18, CYP51A1, GFR, GIPC2, HMGB1, IRF7, JAK3, PSIP1, and VEGF, are cancer-related genes. The results thus demonstrate the potential of q-H2A to contribute to the process of carcinogenesis through epigenetic mechanisms.
Keywords: histone H2A, nickel carcinogenesis, gene expression, cancer-related genes
Abbreviations: MES, 2-(-N-morpholino) ethanosulfonic acid; Ni(II), divalent nickel; q-H2A, truncated human histone H2A.1 lacking the SHHKAKGK C-terminal sequence; wt-H2A, wild-type human histone H2A.1; UHRR, Universal Human Reference RNA
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |